These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 32699345)

  • 1. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.
    Toyoshima Y; Nemoto K; Matsumoto S; Nakamura Y; Kiyotani K
    J Hum Genet; 2020 Dec; 65(12):1075-1082. PubMed ID: 32699345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
    Eaaswarkhanth M; Al Madhoun A; Al-Mulla F
    Int J Infect Dis; 2020 Jul; 96():459-460. PubMed ID: 32464271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
    Xu W; Wang M; Yu D; Zhang X
    Front Immunol; 2020; 11():565278. PubMed ID: 33013929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country.
    Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O
    Front Immunol; 2020; 11():2008. PubMed ID: 33013857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.
    Kumar A; Misra S; Verma V; Vishwakarma RK; Kamal VK; Nath M; Prakash K; Upadhyay AD; Sahu JK
    PLoS One; 2020; 15(10):e0240710. PubMed ID: 33091086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is BCG vaccination affecting the spread and severity of COVID-19?
    Ozdemir C; Kucuksezer UC; Tamay ZU
    Allergy; 2020 Jul; 75(7):1824-1827. PubMed ID: 32330314
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
    Vashi Y; Jagrit V; Kumar S
    Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between HLA gene polymorphisms and mortality of COVID-19: An in silico analysis.
    Tomita Y; Ikeda T; Sato R; Sakagami T
    Immun Inflamm Dis; 2020 Dec; 8(4):684-694. PubMed ID: 33047883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
    Islam MR; Hoque MN; Rahman MS; Alam ASMRU; Akther M; Puspo JA; Akter S; Sultana M; Crandall KA; Hossain MA
    Sci Rep; 2020 Aug; 10(1):14004. PubMed ID: 32814791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.
    de Sousa E; Ligeiro D; Lérias JR; Zhang C; Agrati C; Osman M; El-Kafrawy SA; Azhar EI; Ippolito G; Wang FS; Zumla A; Maeurer M
    Int J Infect Dis; 2020 Sep; 98():454-459. PubMed ID: 32693089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
    Gursel M; Gursel I
    Allergy; 2020 Jul; 75(7):1815-1819. PubMed ID: 32339299
    [No Abstract]   [Full Text] [Related]  

  • 14. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
    Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
    Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and epidemiological characteristics of SARS-CoV-2 in Africa.
    Lamptey J; Oyelami FO; Owusu M; Nkrumah B; Idowu PO; Adu-Gyamfi EA; Czika A; El-Duah P; Yeboah R; Sylverken A; Olasunkanmi OI; Owusu-Dabo E; Drosten C; Adu-Sarkodie Y
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009335. PubMed ID: 33901167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Tomita Y; Sato R; Ikeda T; Sakagami T
    Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
    Rockett RJ; Arnott A; Lam C; Sadsad R; Timms V; Gray KA; Eden JS; Chang S; Gall M; Draper J; Sim EM; Bachmann NL; Carter I; Basile K; Byun R; O'Sullivan MV; Chen SC; Maddocks S; Sorrell TC; Dwyer DE; Holmes EC; Kok J; Prokopenko M; Sintchenko V
    Nat Med; 2020 Sep; 26(9):1398-1404. PubMed ID: 32647358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of risk conferred by coding and regulatory variations of
    Senapati S; Kumar S; Singh AK; Banerjee P; Bhagavatula S
    J Genet; 2020; 99(1):. PubMed ID: 32661206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.